These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26413812)

  • 1. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
    Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
    Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4- and BCR-triggered integrin activation in B-cell chronic lymphocytic leukemia cells depends on JAK2-activated Bruton's tyrosine kinase.
    Montresor A; Toffali L; Rigo A; Ferrarini I; Vinante F; Laudanna C
    Oncotarget; 2018 Oct; 9(80):35123-35140. PubMed ID: 30416684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells.
    Montresor A; Toffali L; Fumagalli L; Constantin G; Rigo A; Ferrarini I; Vinante F; Laudanna C
    J Immunol; 2021 Jul; 207(2):671-684. PubMed ID: 34162728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines.
    Montresor A; Bolomini-Vittori M; Simon SI; Rigo A; Vinante F; Laudanna C
    Cancer Res; 2009 Dec; 69(24):9281-90. PubMed ID: 19934331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK tyrosine kinases promote hierarchical activation of Rho and Rap modules of integrin activation.
    Montresor A; Bolomini-Vittori M; Toffali L; Rossi B; Constantin G; Laudanna C
    J Cell Biol; 2013 Dec; 203(6):1003-19. PubMed ID: 24368807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
    Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
    Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.
    Laufer JM; Lyck R; Legler DF
    FASEB J; 2018 Sep; 32(9):4824-4835. PubMed ID: 29589978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
    Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
    Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
    O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
    PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Janus kinases 1 and 2 regulate chemokine-mediated integrin activation and naïve T-cell homing.
    Pérez-Rivero G; Cascio G; Soriano SF; Sanz ÁG; de Guinoa JS; Rodríguez-Frade JM; Gomariz RP; Holgado BL; Cabañas C; Carrasco YR; Stein JV; Mellado M
    Eur J Immunol; 2013 Jul; 43(7):1745-57. PubMed ID: 23526587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow.
    Shimonaka M; Katagiri K; Nakayama T; Fujita N; Tsuruo T; Yoshie O; Kinashi T
    J Cell Biol; 2003 Apr; 161(2):417-27. PubMed ID: 12707305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12 signaling is independent of Jak2 and Jak3.
    Moriguchi M; Hissong BD; Gadina M; Yamaoka K; Tiffany HL; Murphy PM; Candotti F; O'Shea JJ
    J Biol Chem; 2005 Apr; 280(17):17408-14. PubMed ID: 15611059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOS1, ARHGEF1, and DOCK2 rho-GEFs Mediate JAK-Dependent LFA-1 Activation by Chemokines.
    Toffali L; Montresor A; Mirenda M; Scita G; Laudanna C
    J Immunol; 2017 Jan; 198(2):708-717. PubMed ID: 27986909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
    Ganghammer S; Hutterer E; Hinterseer E; Brachtl G; Asslaber D; Krenn PW; Girbl T; Berghammer P; Geisberger R; Egle A; Zucchetto A; Kruschinski A; Gattei V; Chigaev A; Greil R; Hartmann TN
    Oncotarget; 2015 May; 6(14):12048-60. PubMed ID: 25895128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.
    Csanaky G; Matutes E; Vass JA; Morilla R; Catovsky D
    Leukemia; 1997 Mar; 11(3):408-15. PubMed ID: 9067581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
    Burger M; Hartmann T; Krome M; Rawluk J; Tamamura H; Fujii N; Kipps TJ; Burger JA
    Blood; 2005 Sep; 106(5):1824-30. PubMed ID: 15905192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine unresponsiveness of chronic lymphocytic leukemia cells results from impaired endosomal recycling of Rap1 and is associated with a distinctive type of immunological anergy.
    Pye DS; Rubio I; Pusch R; Lin K; Pettitt AR; Till KJ
    J Immunol; 2013 Aug; 191(3):1496-504. PubMed ID: 23804711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing.
    Dubovsky JA; Chappell DL; Harrington BK; Agrawal K; Andritsos LA; Flynn JM; Jones JA; Paulaitis ME; Bolon B; Johnson AJ; Byrd JC; Muthusamy N
    Blood; 2013 Nov; 122(19):3308-16. PubMed ID: 24009233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
    Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
    HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.